Literature DB >> 24557619

Clinical analysis of 275 cases of acute drug-induced liver disease.

Lei Li1, Wei Jiang, Jiyao Wang.   

Abstract

In order to analyze the causative drugs, clinical manifestation and pathological characteristics of the patients with acute drug-induced liver disease, from January 2000 to December 2005, 275 cases diagnosed as acute drug-induced liver diseases according to Maria Criterion and hospitalized in Zhongshan Hospital of Fudan University were retrospectively reviewed. Each was determined by drug history, clinical symptoms and signs, laboratory tests and therapeutic effects. In 41 cases, the diagnosis was confirmed by liver biopsy. The proportion of acute drug-induced liver disease among all of the acute liver injuries was annually increased. The most common drugs which induced acute liver injuries were traditional Chinese herb medicine (23.3%, 64/275 cases), antineoplastic (15.3%, 42/275), hormones and other immunosuppressant agents (13.8%, 38/275), antihypertensive drugs and other cardiovascular drugs (10.2%, 28/275), NSAIDs (8.7%, 24/275) respectively. Hepatocellular injury was the predominant type in these cases (132 cases, 48%). The principal clinical manifestation included nausea (54.8%), fatigue (50.2%), jaundice (35.6%). 27.9% patients were asymptomatic. Most patients were cured with good prognosis. The total effective rate was 94.2% after treatment. The clinicians should pay attention to the prevention, diagnosis and therapy of drug-induced liver disease.

Entities:  

Year:  2007        PMID: 24557619     DOI: 10.1007/s11684-007-0012-8

Source DB:  PubMed          Journal:  Front Med China        ISSN: 1673-7342


  9 in total

1.  Making a diagnosis of herbal-related toxic hepatitis.

Authors:  Christine A Haller; Jo Ellen Dyer; Richard Ko; Kent R Olson
Journal:  West J Med       Date:  2002-01

Review 2.  Criteria of drug-induced liver disorders. Report of an international consensus meeting.

Authors:  C Bénichou
Journal:  J Hepatol       Date:  1990-09       Impact factor: 25.083

Review 3.  Drug-induced liver disorders: implications for drug development and regulation.

Authors:  N Kaplowitz
Journal:  Drug Saf       Date:  2001       Impact factor: 5.606

Review 4.  Is glucuronidation truly preserved in patients with liver disease?

Authors:  A M Hoyumpa; S Schenker
Journal:  Hepatology       Date:  1991-04       Impact factor: 17.425

5.  Mibefradil withdrawn from the market.

Authors:  S J Billups; B L Carter
Journal:  Ann Pharmacother       Date:  1998 Jul-Aug       Impact factor: 3.154

6.  Development and validation of a clinical scale for the diagnosis of drug-induced hepatitis.

Authors:  V A Maria; R M Victorino
Journal:  Hepatology       Date:  1997-09       Impact factor: 17.425

7.  Hepatitis associated with amoxycillin-clavulanic acid combination report of 15 cases.

Authors:  D Larrey; T Vial; A Micaleff; G Babany; M Morichau-Beauchant; H Michel; J P Benhamou
Journal:  Gut       Date:  1992-03       Impact factor: 23.059

Review 8.  Drug-induced hepatotoxicity: 2005.

Authors:  Willis C Maddrey
Journal:  J Clin Gastroenterol       Date:  2005-04       Impact factor: 3.062

Review 9.  Antituberculosis drug-induced hepatitis: risk factors, prevention and management.

Authors:  Z Hussain; P Kar; S A Husain
Journal:  Indian J Exp Biol       Date:  2003-11       Impact factor: 0.818

  9 in total
  13 in total

1.  Concomitant systemic lupus erythematosus might have a negative impact on the biochemical responses to treatment in patients with primary biliary cholangitis.

Authors:  Xiaoli Fan; Ruoting Men; Ping Ni; Changli Lu; Tengfei Si; Yun Ma; Li Yang
Journal:  Clin Rheumatol       Date:  2019-12-06       Impact factor: 2.980

2.  MiR-122-5p knockdown protects against APAP-mediated liver injury through up-regulating NDRG3.

Authors:  Zhi Yang; Weigang Wu; Pengcheng Ou; Minna Wu; Furong Zeng; Boping Zhou; Shipin Wu
Journal:  Mol Cell Biochem       Date:  2020-11-28       Impact factor: 3.396

Review 3.  Research progress on the protective effects of licorice-derived 18β-glycyrrhetinic acid against liver injury.

Authors:  Shou-Yan Wu; Wen-Jie Wang; Jin-Hui Dou; Li-Kun Gong
Journal:  Acta Pharmacol Sin       Date:  2020-03-06       Impact factor: 6.150

4.  Prediction of oral hepatotoxic dose of natural products derived from traditional Chinese medicines based on SVM classifier and PBPK modeling.

Authors:  Size Li; Yiqun Yu; Xiaolan Bian; Li Yao; Min Li; Yan-Ru Lou; Jing Yuan; Hai-Shu Lin; Lucy Liu; Bing Han; Xiaoqiang Xiang
Journal:  Arch Toxicol       Date:  2021-03-13       Impact factor: 5.153

5.  A Multicenter and Randomized Controlled Trial of Bicyclol in the Treatment of Statin-Induced Liver Injury.

Authors:  Wu Naiqiong; Wang Liansheng; Han Zhanying; Guo Yuanlin; Zhu Chenggang; Gao Ying; Dong Qian; Liu Dongchen; Zhou Yanjun; Li Jianjun
Journal:  Med Sci Monit       Date:  2017-12-04

6.  CSH guidelines for the diagnosis and treatment of drug-induced liver injury.

Authors:  Yue-Cheng Yu; Yi-Min Mao; Cheng-Wei Chen; Jin-Jun Chen; Jun Chen; Wen-Ming Cong; Yang Ding; Zhong-Ping Duan; Qing-Chun Fu; Xiao-Yan Guo; Peng Hu; Xi-Qi Hu; Ji-Dong Jia; Rong-Tao Lai; Dong-Liang Li; Ying-Xia Liu; Lun-Gen Lu; Shi-Wu Ma; Xiong Ma; Yue-Min Nan; Hong Ren; Tao Shen; Hao Wang; Ji-Yao Wang; Tai-Ling Wang; Xiao-Jin Wang; Lai Wei; Qing Xie; Wen Xie; Chang-Qing Yang; Dong-Liang Yang; Yan-Yan Yu; Min-de Zeng; Li Zhang; Xin-Yan Zhao; Hui Zhuang
Journal:  Hepatol Int       Date:  2017-04-12       Impact factor: 6.047

Review 7.  Traditional Chinese Medicine and Herb-induced Liver Injury: Comparison with Drug-induced Liver Injury.

Authors:  Jing Jing; Rolf Teschke
Journal:  J Clin Transl Hepatol       Date:  2017-10-27

8.  [Expert panel consensus statement on prevention and standardized treatment of drug-induced liver injury in patients with blood diseases (2016)].

Authors: 
Journal:  Zhonghua Xue Ye Xue Za Zhi       Date:  2016-06-14

9.  Risk factors for acute liver failure among inpatients with anti-tuberculosis drug-induced liver injury.

Authors:  Shuting Wang; Yanwan Shangguan; Cheng Ding; Pengcheng Li; Zhongkang Ji; Jundan Shao; Hong Fang; Meifang Yang; Pei Shi; Jie Wu; Jingjing Ren; Shigui Yang; Jing Yuan; Yunzhen Shi; Jingnan Li; Lanjuan Li; Kaijin Xu
Journal:  J Int Med Res       Date:  2018-11-26       Impact factor: 1.671

Review 10.  Suspected drug-induced liver injury associated with iguratimod: a case report and review of the literature.

Authors:  Xiao-Li Li; Xiao-Chang Liu; Yu-Lin Song; Ru-Tao Hong; Hai Shi
Journal:  BMC Gastroenterol       Date:  2018-08-24       Impact factor: 3.067

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.